Horizon Therapeutics
(NASDAQ) HZNP
Horizon Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$3.64B
Net Income (TTM)
$438.00M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
HZNP News
HZNP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Horizon Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
2,115
CEO
Timothy P. Walbert
Website
www.horizontherapeutics.comHeadquarters
Dublin, 2, IE
HZNP Financials
Key Financial Metrics (TTM)
Gross Margin
75%
Operating Margin
17%
Net Income Margin
14%
Return on Equity
11%
Return on Capital
8%
Return on Assets
6%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.71B
Operating Income
$617.41M
EBITDA
$1.11B
Operating Cash Flow
$1.26B
Capital Expenditure
$126.28M
Free Cash Flow
$1.13B
Cash & ST Invst.
$2.35B
Total Debt
$2.56B
Horizon Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$944.96M
+7.8%
Gross Profit
$725.00M
+12.2%
Gross Margin
76.72%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
2,190
N/A
Net Income
$127.07M
+108.4%
EBITDA
$243.63M
+2.6%
Quarterly Fundamentals
Net Cash
$92.83M
+86.2%
Accounts Receivable
$717.42M
+6.6%
Inventory
$170.32M
-16.4%
Long Term Debt
$2.54B
-0.4%
Short Term Debt
$16.00M
+0.0%
Return on Assets
5.72%
N/A
Return on Invested Capital
7.56%
N/A
Free Cash Flow
$143.00M
-40.2%
Operating Cash Flow
$161.47M
-35.2%